Update: 13.01.2025
Last week: 52 week 2025 (22.12.2025 - 28.12.2025)
Last full month: November 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 590 | -7.4% | 15.1% | -0.3 | 22 828 042 | -6.9% | 11.5% | -0.1 | -5.8% |
| MoM | 49 324 | -3.8% | 15.1% | 0.4 | 113 646 200 | -3.1% | 11.3% | 0.4 | -6.6% |
| YTD | 494 057 | 17.2% | 13.7% | 1.4 | 1 117 755 967 | 33.2% | 10.3% | 1 | 5.2% |
| MAT | 494 057 | 17.2% | 13.7% | 1.4 | 1 117 755 967 | 33.2% | 10.3% | 1 | 5.2% |
| BRAINMAX | |||||||||
| WoW | 5 682 | -1.8% | 100.0% | 0 | 8 494 192 | -2.1% | 100.0% | 0 | -1.8% |
| MoM | 31 686 | 95.0% | 100.0% | 0 | 49 079 183 | 31.2% | 100.0% | 0 | 95.0% |
| YTD | 162 130 | 96.1% | 100.0% | 0 | 434 487 911 | 51.5% | 100.0% | 0 | 96.1% |
| MAT | 162 130 | 96.1% | 100.0% | 0 | 434 487 911 | 51.5% | 100.0% | 0 | 96.1% |
| GOLDLINE PLUS | |||||||||
| WoW | 12 727 | -1.5% | 46.3% | 0.1 | 41 929 575 | -0.3% | 38.7% | 0.6 | -1.7% |
| MoM | 57 189 | 0.5% | 46.6% | 0.4 | 188 320 057 | -0.9% | 39.1% | 0.5 | -0.4% |
| YTD | 760 060 | -8.3% | 45.9% | 0.5 | 2 479 249 414 | -4.7% | 37.8% | 0.6 | -9.3% |
| MAT | 760 060 | -8.3% | 45.9% | 0.5 | 2 479 249 414 | -4.7% | 37.8% | 0.6 | -9.3% |
| MIGRENIUM | |||||||||
| WoW | 8 629 | -4.9% | 0.3% | 0 | 3 078 452 | -5.2% | 0.4% | 0 | 4.2% |
| MoM | 35 009 | -3.5% | 0.4% | 0 | 12 606 320 | -3.4% | 0.5% | 0 | -5.5% |
| YTD | 428 564 | -24.5% | 0.3% | -0.1 | 152 250 966 | -16.2% | 0.5% | -0.2 | 5.0% |
| MAT | 428 564 | -24.5% | 0.3% | -0.1 | 152 250 966 | -16.2% | 0.5% | -0.2 | 5.0% |
| MODELAX-N | |||||||||
| WoW | 27 763 | -0.2% | 18.1% | -0.1 | 17 467 068 | 1.2% | 13.9% | -0.3 | 0.4% |
| MoM | 121 017 | 0.4% | 19.0% | -0.5 | 72 885 130 | -0.8% | 14.4% | -0.4 | 2.8% |
| YTD | 1 437 950 | -1.7% | 19.7% | -2 | 805 549 815 | 22.2% | 14.5% | 0.3 | 8.4% |
| MAT | 1 437 950 | -1.7% | 19.7% | -2 | 805 549 815 | 22.2% | 14.5% | 0.3 | 8.4% |
| REDUXIN | |||||||||
| WoW | 7 820 | -8.6% | 28.5% | -2.1 | 43 690 886 | -6.3% | 40.4% | -1.9 | -1.7% |
| MoM | 37 124 | -2.1% | 30.2% | -0.5 | 198 064 287 | -3.2% | 41.1% | -0.4 | -0.4% |
| YTD | 519 362 | -12.8% | 31.4% | -1.2 | 2 823 616 645 | -10.7% | 43.0% | -2.1 | -9.3% |
| MAT | 519 362 | -12.8% | 31.4% | -1.2 | 2 823 616 645 | -10.7% | 43.0% | -2.1 | -9.3% |
| REDUXIN FORTE | |||||||||
| WoW | 2 652 | -1.2% | 9.7% | 0.1 | 13 604 543 | -1.3% | 12.6% | 0.1 | -1.7% |
| MoM | 12 415 | -5.8% | 10.1% | -0.6 | 61 299 440 | -5.1% | 12.7% | -0.4 | -0.4% |
| YTD | 168 716 | 0.8% | 10.2% | 1 | 791 855 639 | 9.7% | 12.1% | 1.8 | -9.3% |
| MAT | 168 716 | 0.8% | 10.2% | 1 | 791 855 639 | 9.7% | 12.1% | 1.8 | -9.3% |
| SALVISAR | |||||||||
| WoW | 11 527 | -5.8% | 1.6% | -0.1 | 6 560 349 | -7.3% | 1.6% | -0.1 | 0.4% |
| MoM | 65 360 | 24.4% | 2.0% | 0.4 | 36 168 190 | 25.3% | 2.1% | 0.4 | -2.0% |
| YTD | 624 893 | 9.3% | 1.7% | 0.2 | 326 934 648 | 35.7% | 1.6% | 0.3 | -2.6% |
| MAT | 624 893 | 9.3% | 1.7% | 0.2 | 326 934 648 | 35.7% | 1.6% | 0.3 | -2.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 494 057 | 17.2% | 13.7% | 1.4 | 1 117 755 967 | 33.2% | 10.3% | 1 | 5.2% |
| BRAINMAX | 162 130 | 96.1% | 100.0% | 0 | 434 487 911 | 51.5% | 100.0% | 0 | 96.1% |
| GOLDLINE PLUS | 760 060 | -8.3% | 45.9% | 0.5 | 2 479 249 414 | -4.7% | 37.8% | 0.6 | -9.3% |
| MIGRENIUM | 428 564 | -24.5% | 0.3% | -0.1 | 152 250 966 | -16.2% | 0.5% | -0.2 | 5.0% |
| MODELAX-N | 1 437 950 | -1.7% | 19.7% | -2 | 805 549 815 | 22.2% | 14.5% | 0.3 | 8.4% |
| REDUXIN CAPS | 519 362 | -12.8% | 31.4% | -1.2 | 2 823 616 645 | -10.7% | 43.0% | -2.1 | -9.3% |
| REDUXIN FORTE | 168 716 | 0.8% | 10.2% | 1 | 791 855 639 | 9.7% | 12.1% | 1.8 | -9.3% |
| SALVISAR | 624 893 | 9.3% | 1.7% | 0.2 | 326 934 648 | 35.7% | 1.6% | 0.3 | -2.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 494 057 | 17.2% | 13.7% | 1.4 | 1 117 755 967 | 33.2% | 10.3% | 1 | 5.2% |
| BRAINMAX | 162 130 | 96.1% | 100.0% | 0 | 434 487 911 | 51.5% | 100.0% | 0 | 96.1% |
| GOLDLINE PLUS | 760 060 | -8.3% | 45.9% | 0.5 | 2 479 249 414 | -4.7% | 37.8% | 0.6 | -9.3% |
| MIGRENIUM | 428 564 | -24.5% | 0.3% | -0.1 | 152 250 966 | -16.2% | 0.5% | -0.2 | 5.0% |
| MODELAX-N | 1 437 950 | -1.7% | 19.7% | -2 | 805 549 815 | 22.2% | 14.5% | 0.3 | 8.4% |
| REDUXIN CAPS | 519 362 | -12.8% | 31.4% | -1.2 | 2 823 616 645 | -10.7% | 43.0% | -2.1 | -9.3% |
| REDUXIN FORTE | 168 716 | 0.8% | 10.2% | 1 | 791 855 639 | 9.7% | 12.1% | 1.8 | -9.3% |
| SALVISAR | 624 893 | 9.3% | 1.7% | 0.2 | 326 934 648 | 35.7% | 1.6% | 0.3 | -2.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 590 | -7.4% | 15.1% | -0.3 | 22 828 042 | -6.9% | 11.5% | -0.1 | -5.8% |
| BRAINMAX | 5 682 | -1.8% | 100.0% | 0 | 8 494 192 | -2.1% | 100.0% | 0 | -1.8% |
| GOLDLINE PLUS | 12 727 | -1.5% | 46.3% | 0.1 | 41 929 575 | -0.3% | 38.7% | 0.6 | -1.7% |
| MIGRENIUM | 8 629 | -4.9% | 0.3% | 0 | 3 078 452 | -5.2% | 0.4% | 0 | 4.2% |
| MODELAX-N | 27 763 | -0.2% | 18.1% | -0.1 | 17 467 068 | 1.2% | 13.9% | -0.3 | 0.4% |
| REDUXIN CAPS | 7 820 | -8.6% | 28.5% | -2.1 | 43 690 886 | -6.3% | 40.4% | -1.9 | -1.7% |
| REDUXIN FORTE | 2 652 | -1.2% | 9.7% | 0.1 | 13 604 543 | -1.3% | 12.6% | 0.1 | -1.7% |
| SALVISAR | 11 527 | -5.8% | 1.6% | -0.1 | 6 560 349 | -7.3% | 1.6% | -0.1 | 0.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 49 324 | -3.8% | 15.1% | 0.4 | 113 646 200 | -3.1% | 11.3% | 0.4 | -6.6% |
| BRAINMAX | 31 686 | 95.0% | 100.0% | 0 | 49 079 183 | 31.2% | 100.0% | 0 | 95.0% |
| GOLDLINE PLUS | 57 189 | 0.5% | 46.6% | 0.4 | 188 320 057 | -0.9% | 39.1% | 0.5 | -0.4% |
| MIGRENIUM | 35 009 | -3.5% | 0.4% | 0 | 12 606 320 | -3.4% | 0.5% | 0 | -5.5% |
| MODELAX-N | 121 017 | 0.4% | 19.0% | -0.5 | 72 885 130 | -0.8% | 14.4% | -0.4 | 2.8% |
| REDUXIN CAPS | 37 124 | -2.1% | 30.2% | -0.5 | 198 064 287 | -3.2% | 41.1% | -0.4 | -0.4% |
| REDUXIN FORTE | 12 415 | -5.8% | 10.1% | -0.6 | 61 299 440 | -5.1% | 12.7% | -0.4 | -0.4% |
| SALVISAR | 65 360 | 24.4% | 2.0% | 0.4 | 36 168 190 | 25.3% | 2.1% | 0.4 | -2.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N SOL RECTAL USE 12.9 MG/ML+102.6 MG/ML+625 MG/ML 5 ML #20"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N SOL RECTAL USE 12.9 MG/ML+102.6 MG/ML+625 MG/ML 5 ML #20"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs